n/a
Abstract Title:

Berberine attenuates olanzapine induced-metabolic syndrome.

Abstract Source:

J Pak Med Assoc. 2019 Aug ;69(Suppl 3)(8):S88-S92. PMID: 31603885

Abstract Author(s):

Marwa Salih Al-Naimi, Huda Abdulbaki Rasheed, Hayder M Al-Kuraishy, Ali I Al-Gareeb

Article Affiliation:

Marwa Salih Al-Naimi

Abstract:

Objective: To elucidate the protective effect of berberine on olanzapine induced-metabolic syndrome.

Methods: This prospective experimental study involved thirty Sprague-Dawley male rats which were divided into three groups. Group A (n=10): Rats treated with distilled water, Group B (n=10): Rats treated with olanzapine, Group C (n=10): Rats treated with olanzapine plus berberine. The duration of the study was 8 weeks, baseline and follow up data were evaluated. Fasting blood glucose(FBG) total cholesterol (TC), triglyceride (TG) and high-density lipoprotein (HDL), Low density lipoprotein (LDL), atherogenic index of plasma (AI), fasting serum insulin level, insulin resistance,β- cell function and insulin sensitivity were evaluated.SPSS 20.

Results: Olanzepine led to significant deterioration in gluco-metabolic profile compared with control P<0.01. Olanzapine plus berberine improved body weight, FBG, FSI, HOMA-IR and QUICKI compared with olanzapine P=0.0001.

Conclusions: Berberine attenuates olanzapine induced-metabolic via amelioration of gluco-lipid disturbances.

Study Type : Animal Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.